RZOLV Technologies Inc. (TSXV: RZL) (OTCQB: RZOLF) ("RZOLV" or the "Company") today announced the results of an ecotoxicity report prepared by Centre Technologique des Résidus Industriels ("CTRI"), a ...
TruLarv ™ is considered a non-animal technology (NAT) in the context of UK animal use regulations (ASPA) where procedures on this species are not regulated. We carried out a study in partnership with ...
Washington -- A report outlining the findings of the international expert workshop "Alternative Approaches for Identifying Acute Systemic Toxicity: Moving From Research to Regulatory Testing" was ...
Toxicity-testing strategies designed to generate information on potential hazards or risks posed by environmental agents have evolved in response to legislative mandates, scientific developments, and ...
KENT, Wash.--(BUSINESS WIRE)--UtilX ® Corporation’s patented next-generation fluid, CableCURE ® /DMDB, gained another impressive accolade when it passed the California Environmental Protection ...
The committee explored whether DOD could adopt a modern testing strategy for the prediction of acute toxicity. 3 In particular, the committee’s statement of task required a focus on the assessment of ...
Because little is known regarding the toxicity of PFAS-free AFFF formulations, the first phase of our project was focused on acute toxicity trials (e.g.., range-finding studies, lethal concentration ...
Biocompatibility testing is a necessary part of any medical device validation process. It is governed by FDA’s ISO 10993 guidance document, a seemingly rigid statement that provides a general matrix ...
RZOLV Technologies Inc. (TSXV: RZL) (OTCQB: RZOLF) ("RZOLV" or the "Company") today announced the results of an ecotoxicity report prepared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results